Cargando…
In Vitro and In Vivo Trypanocidal Activity of H(2)bdtc-Loaded Solid Lipid Nanoparticles
The parasite Trypanosoma cruzi causes Chagas disease, which remains a serious public health concern and continues to victimize thousands of people, primarily in the poorest regions of Latin America. In the search for new therapeutic drugs against T. cruzi, here we have evaluated both the in vitro an...
Autores principales: | Carneiro, Zumira A., da S. Maia, Pedro I., Sesti-Costa, Renata, Lopes, Carla D., Pereira, Tatiana A., Milanezi, Cristiane M., da Silva, Marcelo A. Pereira., Lopez, Renata F. V., Silva, João S., Deflon, Victor M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014426/ https://www.ncbi.nlm.nih.gov/pubmed/24810753 http://dx.doi.org/10.1371/journal.pntd.0002847 |
Ejemplares similares
-
Correction: In Vitro and In Vivo Trypanocidal Activity of H2bdtc-Loaded Solid Lipid Nanoparticles
Publicado: (2015) -
Ruthenium Complex with Benznidazole and Nitric Oxide as a New Candidate for the Treatment of Chagas Disease
por: Sesti-Costa, Renata, et al.
Publicado: (2014) -
Non-peptidic Cruzain Inhibitors with Trypanocidal Activity Discovered by Virtual Screening and In Vitro Assay
por: Wiggers, Helton J., et al.
Publicado: (2013) -
Trypanocidal Essential Oils: A Review
por: de Morais, Mayara Castro, et al.
Publicado: (2020) -
In vitro genotoxicity of nitroimidazoles as a tool in the
search of new trypanocidal agents
por: Von Trompowsky, Ana Claudia Manoel, et al.
Publicado: (2019)